{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:24:56Z","timestamp":1781259896431,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We sought to analyse plasma levels of peripheral blood microRNAs (miRs) as biomarkers of ST-segment-elevation myocardial infarction (STEMI) due to type-1 myocardial infarction as a model situation of vulnerable plaque (VP) rupture. Samples of 20 patients with STEMI were compared both with a group of patients without angina pectoris in whom coronary angiogram did not reveal coronary atherosclerotic disease (no coronary atherosclerosis-NCA) and a group of patients with stable angina pectoris and at least one significant coronary artery stenosis (stable coronary artery disease-SCAD). This study design allowed us to identify miRs deregulated in the setting of acute coronary artery occlusion due to VP rupture. Based on an initial large scale miR assay screening, we selected a total of 12 miRs (three study miRs and nine controls) that were tested in the study. Two of the study miRs (miR-331 and miR-151-3p) significantly distinguished STEMI patients from the control groups, while ROC analysis confirmed their suitability as biomarkers. Importantly, this was observed in patients presenting early with STEMI, even before the markers of myocardial necrosis (cardiac troponin I, miR-208 and miR-499) were elevated, which suggests that the origin of miR-331 and miR-151-3p might be in the VP. In conclusion, the study provides two novel biomarkers observed in STEMI, which may be associated with plaque rupture.<\/jats:p>","DOI":"10.1038\/s41598-020-62835-w","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:06:32Z","timestamp":1585908392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["MicroRNA-331 and microRNA-151-3p as biomarkers in patients with ST-segment elevation myocardial infarction"],"prefix":"10.1038","volume":"10","author":[{"given":"Martin","family":"Horv\u00e1th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Horv\u00e1thov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"H\u00e1jek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"\u0160t\u011bchovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Hon\u011bk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Veselka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"62835_CR1","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","volume":"37","author":"N Townsend","year":"2016","unstructured":"Townsend, N. et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 37, 3232\u20133245 (2016).","journal-title":"Eur. Heart J."},{"key":"62835_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.CIR.79.4.733","volume":"79","author":"JE Muller","year":"1989","unstructured":"Muller, J. E., Tofler, G. H. & Stone, P. H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 79, 733\u201343 (1989).","journal-title":"Circulation"},{"key":"62835_CR3","first-page":"19","volume":"48","author":"M Friedman","year":"1966","unstructured":"Friedman, M. & Van den Bovenkamp, G. J. The pathogenesis of a coronary thrombus. Am. J. Pathol. 48, 19\u201344 (1966).","journal-title":"Am. J. Pathol."},{"key":"62835_CR4","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","volume":"129","author":"AS Go","year":"2014","unstructured":"Go, A. S. et al. Heart Disease and Stroke Statistics\u20142014 Update. Circulation 129, e28\u2013e292 (2014).","journal-title":"Circulation"},{"key":"62835_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMra1201534","volume":"369","author":"CJL Murray","year":"2013","unstructured":"Murray, C. J. L. & Lopez, A. D. Measuring the Global Burden of Disease. N. Engl. J. Med. 369, 448\u2013457 (2013).","journal-title":"N. Engl. J. Med."},{"key":"62835_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.amjmed.2010.08.015","volume":"124","author":"M Franco","year":"2011","unstructured":"Franco, M., Cooper, R. S., Bilal, U. & Fuster, V. Challenges and Opportunities for Cardiovascular Disease Prevention. Am. J. Med. 124, 95\u2013102 (2011).","journal-title":"Am. J. Med."},{"key":"62835_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","volume":"118","author":"MW Feinberg","year":"2016","unstructured":"Feinberg, M. W. & Moore, K. J. MicroRNA Regulation of Atherosclerosis. Circ. Res. 118, 703\u2013720 (2016).","journal-title":"Circ. Res."},{"key":"62835_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2015.06.037","volume":"241","author":"EK Economou","year":"2015","unstructured":"Economou, E. K. et al. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment. Atherosclerosis 241, 624\u201333 (2015).","journal-title":"Atherosclerosis"},{"key":"62835_CR9","doi-asserted-by":"publisher","unstructured":"Kaudewitz, D., Zampetaki, A. & Mayr, M. MicroRNA Biomarkers for Coronary Artery Disease? Genetics, https:\/\/doi.org\/10.1007\/s11883-015-0548-z (2015).","DOI":"10.1007\/s11883-015-0548-z"},{"key":"62835_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11883-015-0548-z","volume":"17","author":"D Kaudewitz","year":"2015","unstructured":"Kaudewitz, D., Zampetaki, A. & Mayr, M. MicroRNA Biomarkers for Coronary Artery Disease? Curr. Atheroscler. Rep. 17, 70 (2015).","journal-title":"Curr. Atheroscler. Rep."},{"key":"62835_CR11","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1161\/ATVBAHA.111.226696","volume":"31","author":"S Fichtlscherer","year":"2011","unstructured":"Fichtlscherer, S., Zeiher, A. M. & Dimmeler, S. Circulating MicroRNAs. Arterioscler. Thromb. Vasc. Biol. 31, 2383\u20132390 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"62835_CR12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/eurheartj\/ehw047","volume":"37","author":"DM Leistner","year":"2016","unstructured":"Leistner, D. M. et al. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics. Eur. Heart J. 37, 1738\u20131749 (2016).","journal-title":"Eur. Heart J."},{"key":"62835_CR13","doi-asserted-by":"publisher","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Eur. Heart J., https:\/\/doi.org\/10.1093\/eurheartj\/ehy462 (2018).","DOI":"10.1093\/eurheartj\/ehy462"},{"key":"62835_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1590\/S0100-879X2007001100003","volume":"40","author":"DL Zanette","year":"2007","unstructured":"Zanette, D. L. et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Brazilian J. Med. Biol. Res. = Rev. Bras. Pesqui. medicas e Biol. 40, 1435\u201340 (2007).","journal-title":"Brazilian J. Med. Biol. Res. = Rev. Bras. Pesqui. medicas e Biol."},{"key":"62835_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3892\/or.2015.4450","volume":"35","author":"D Zhao","year":"2016","unstructured":"Zhao, D., Sui, Y. & Zheng, X. miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K\/Akt and ERK1\/2 pathways in colorectal cancer. Oncol. Rep. 35, 1075\u20131082 (2016).","journal-title":"Oncol. Rep."},{"key":"62835_CR16","doi-asserted-by":"publisher","first-page":"24696","DOI":"10.1074\/jbc.M109.030098","volume":"284","author":"MR Epis","year":"2009","unstructured":"Epis, M. R., Giles, K. M., Barker, A., Kendrick, T. S. & Leedman, P. J. miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. J. Biol. Chem. 284, 24696\u2013704 (2009).","journal-title":"J. Biol. Chem."},{"key":"62835_CR17","unstructured":"Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients. - PubMed - NCBI. Available at, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25620533. (Accessed: 14th October 2018)."},{"key":"62835_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-5-25","volume":"5","author":"MC Pahl","year":"2012","unstructured":"Pahl, M. C. et al. MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med. Genomics 5, 25 (2012).","journal-title":"BMC Med. Genomics"},{"key":"62835_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2010.03.011","volume":"263","author":"AJ Luers","year":"2010","unstructured":"Luers, A. J., Loudig, O. D. & Berman, J. W. MicroRNAs are expressed and processed by human primary macrophages. Cell. Immunol. 263, 1\u20138 (2010).","journal-title":"Cell. Immunol."},{"key":"62835_CR20","first-page":"136","volume":"8","author":"AR Naqvi","year":"2016","unstructured":"Naqvi, A. R. et al. Expression Profiling of LPS Responsive miRNA in Primary Human Macrophages. J. Microb. Biochem. Technol. 8, 136\u2013143 (2016).","journal-title":"J. Microb. Biochem. Technol."},{"key":"62835_CR21","doi-asserted-by":"publisher","first-page":"A51","DOI":"10.1136\/hrt.2010.214833","volume":"97","author":"L Xiao","year":"2011","unstructured":"Xiao, L., Ming, H., Tao, C. & Yuliang, W. The expression of SOCS is altered in atherosclerosis. Heart 97, A51\u2013A51 (2011).","journal-title":"Heart"},{"key":"62835_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1159\/000430303","volume":"36","author":"Y Yang","year":"2015","unstructured":"Yang, Y., Yang, L., Liang, X. & Zhu, G. MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1. Cell. Physiol. Biochem. 36, 1371\u201381 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"62835_CR23","doi-asserted-by":"publisher","first-page":"e90563","DOI":"10.1371\/journal.pone.0090563","volume":"9","author":"C Zhai","year":"2014","unstructured":"Zhai, C. et al. Selective Inhibition of PI3K\/Akt\/mTOR Signaling Pathway Regulates Autophagy of Macrophage and Vulnerability of Atherosclerotic Plaque. Plos One 9, e90563 (2014).","journal-title":"Plos One"},{"key":"62835_CR24","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/01.ATV.0000043453.21629.3B","volume":"22","author":"N Auge","year":"2002","unstructured":"Auge, N. et al. Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor\/PI-3 Kinase\/Akt and the Sphingolipid Signaling Pathways. Arterioscler. Thromb. Vasc. Biol. 22, 1990\u20131995 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"62835_CR25","unstructured":"Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma|Read by QxMD. Available at, https:\/\/www.readbyqxmd.com\/read\/23458262\/concomitant-dysregulation-of-micrornas-mir-151-3p-and-mir-126-correlates-with-improved-survival-in-resected-cholangiocarcinoma, (Accessed: 14th October 2018)."},{"key":"62835_CR26","doi-asserted-by":"publisher","first-page":"e0168171","DOI":"10.1371\/journal.pone.0168171","volume":"11","author":"T-C Yeh","year":"2016","unstructured":"Yeh, T.-C. et al. miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells. Plos One 11, e0168171 (2016).","journal-title":"Plos One"},{"key":"62835_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/cmi.2017.82","volume":"15","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. MicroRNA in vivo precipitation identifies miR-151-3p as a computational unpredictable miRNA to target Stat3 and inhibits innate IL-6 production. Cell. Mol. Immunol. 15, 99\u2013110 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"62835_CR28","doi-asserted-by":"publisher","first-page":"H1762","DOI":"10.1152\/ajpheart.00829.2010","volume":"300","author":"C-W Ni","year":"2011","unstructured":"Ni, C.-W., Qiu, H. & Jo, H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am. J. Physiol. Circ. Physiol. 300, H1762\u2013H1769 (2011).","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"62835_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/BF03086163","volume":"16","author":"HC Groen","year":"2008","unstructured":"Groen, H. C. et al. High shear stress influences plaque vulnerability Part of the data presented in this paper were published in Stroke 2007;38:2379\u201381. Neth. Heart J. 16, 280\u20133 (2008).","journal-title":"Neth. Heart J."},{"key":"62835_CR30","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1161\/CIRCULATIONAHA.105.590018","volume":"113","author":"C Cheng","year":"2006","unstructured":"Cheng, C. et al. Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress. Circulation 113, 2744\u20132753 (2006).","journal-title":"Circulation"},{"key":"62835_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrcardio.2015.203","volume":"13","author":"AJ Brown","year":"2016","unstructured":"Brown, A. J. et al. Role of biomechanical forces in the natural history of coronary atherosclerosis. Nat. Rev. Cardiol. 13, 210\u2013220 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"62835_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.clinbiochem.2013.02.018","volume":"46","author":"S Rome","year":"2013","unstructured":"Rome, S. Are extracellular microRNAs involved in type 2 diabetes and related pathologies? Clin. Biochem. 46, 937\u2013945 (2013).","journal-title":"Clin. Biochem."},{"key":"62835_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1253\/circj.CJ-14-0958","volume":"79","author":"T Soeki","year":"2015","unstructured":"Soeki, T. et al. Plasma MicroRNA-100 Is Associated With Coronary Plaque Vulnerability. Circ. J. 79, 413\u2013418 (2015).","journal-title":"Circ. J."},{"key":"62835_CR34","first-page":"1","volume":"2016","author":"RY Cao","year":"2016","unstructured":"Cao, R. Y. et al. The Emerging Role of MicroRNA-155 in Cardiovascular Diseases. Biomed Res. Int. 2016, 1\u20135 (2016).","journal-title":"Biomed Res. Int."},{"key":"62835_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-015-0148-y","volume":"20","author":"C Li","year":"2015","unstructured":"Li, C., Chen, X., Huang, J., Sun, Q. & Wang, L. Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction. Eur. J. Med. Res. 20, 58 (2015).","journal-title":"Eur. J. Med. Res."},{"key":"62835_CR36","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","volume":"47","author":"R Virmani","year":"2006","unstructured":"Virmani, R., Burke, A. P., Farb, A. & Kolodgie, F. D. Pathology of the Vulnerable Plaque. J. Am. Coll. Cardiol. 47, C13\u2013C18 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62835_CR37","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon, J. F., Otsuka, F., Virmani, R. & Falk, E. Mechanisms of Plaque Formation and Rupture. Circ. Res. 114, 1852\u20131866 (2014).","journal-title":"Circ. Res."},{"key":"62835_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/CIRCRESAHA.111.300539","volume":"112","author":"P Willeit","year":"2013","unstructured":"Willeit, P. et al. Circulating MicroRNAs as Novel Biomarkers for Platelet Activation. Circ. Res. 112, 595\u2013600 (2013).","journal-title":"Circ. Res."},{"key":"62835_CR39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.309303","volume":"120","author":"N Sunderland","year":"2017","unstructured":"Sunderland, N. et al. MicroRNA Biomarkers and Platelet Reactivity. Circ. Res. 120, 418\u2013435 (2017).","journal-title":"Circ. Res."},{"key":"62835_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2013-03-492801","volume":"122","author":"B Laffont","year":"2013","unstructured":"Laffont, B. et al. Activated platelets can deliver mRNA regulatory Ago2bulletmicroRNA complexes to endothelial cells via microparticles. Blood 122, 253\u2013261 (2013).","journal-title":"Blood"},{"key":"62835_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fendo.2018.00074","volume":"9","author":"J Pordzik","year":"2018","unstructured":"Pordzik, J. et al. The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review. Front. Endocrinol. (Lausanne). 9, 74 (2018).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"62835_CR42","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1373\/clinchem.2014.224238","volume":"60","author":"B Meder","year":"2014","unstructured":"Meder, B. et al. Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin. Chem. 60, 1200\u20138 (2014).","journal-title":"Clin. Chem."},{"key":"62835_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 39, 119\u2013177 (2018).","journal-title":"Eur. Heart J."},{"key":"62835_CR44","doi-asserted-by":"publisher","first-page":"14305","DOI":"10.3390\/ijms160714305","volume":"16","author":"M-H Bao","year":"2015","unstructured":"Bao, M.-H. et al. Meta-Analysis of miR-146a Polymorphisms Association with Coronary Artery Diseases and Ischemic Stroke. Int. J. Mol. Sci 16, 14305\u201314317 (2015).","journal-title":"Int. J. Mol. Sci"},{"key":"62835_CR45","first-page":"4285942","volume":"2016","author":"J Wang","year":"2016","unstructured":"Wang, J., Yan, Y., Song, D. & Liu, B. Reduced Plasma miR-146a Is a Predictor of Poor Coronary Collateral Circulation in Patients with Coronary Artery Disease. Biomed Res. Int. 2016, 4285942 (2016).","journal-title":"Biomed Res. Int."},{"key":"62835_CR46","doi-asserted-by":"publisher","unstructured":"Raitoharju, E., Oksala, N. & Lehtim\u00e4ki, T. MicroRNAs in the Atheroclerotic Plaque, https:\/\/doi.org\/10.1373\/clinchem.2013.204917 (2013).","DOI":"10.1373\/clinchem.2013.204917"},{"key":"62835_CR47","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1159\/000430302","volume":"36","author":"X Zhu","year":"2015","unstructured":"Zhu, X. et al. Investigating the Role of the Posttranscriptional Gene Regulator MiR-24- 3p in the Proliferation, Migration and Apoptosis of Human Arterial Smooth Muscle Cells in Arteriosclerosis Obliterans. Cell. Physiol. Biochem. 36, 1359\u201370 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"62835_CR48","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/ATVBAHA.114.304088","volume":"34","author":"K Di Gregoli","year":"2014","unstructured":"Di Gregoli, K. et al. MicroRNA-24 Regulates Macrophage Behavior and Retards Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 34, 1990\u20132000 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"62835_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ijcard.2014.07.068","volume":"176","author":"AP Pilbrow","year":"2014","unstructured":"Pilbrow, A. P. et al. Circulating miR-323-3p and miR-652: Candidate markers for the presence and progression of acute coronary syndromes. Int. J. Cardiol. 176, 375\u2013385 (2014).","journal-title":"Int. J. Cardiol."},{"key":"62835_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"62835_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2016.01.129","volume":"207","author":"S Li","year":"2016","unstructured":"Li, S., Chen, H., Song, J., Lee, C. & Geng, Q. Avoiding heparin inhibition in circulating MicroRNAs amplification. Int. J. Cardiol. 207, 92\u201393 (2016).","journal-title":"Int. J. Cardiol."},{"key":"62835_CR52","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1093\/nar\/19.21.6051","volume":"19","author":"S Izraeli","year":"1991","unstructured":"Izraeli, S., Pfleiderer, C. & Lion, T. Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood. Nucleic Acids Res. 19, 6051 (1991).","journal-title":"Nucleic Acids Res."},{"key":"62835_CR53","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2144\/03356bm03","volume":"35","author":"ML Johnson","year":"2003","unstructured":"Johnson, M. L., Navanukraw, C., Grazul-Bilska, A. T., Reynolds, L. P. & Redmer, D. A. Heparinase treatment of RNA before quantitative real-time RT-PCR. Biotechniques 35, 1140\u20131144 (2003).","journal-title":"Biotechniques"},{"key":"62835_CR54","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1160\/TH13-05-0368","volume":"110","author":"D Kaudewitz","year":"2013","unstructured":"Kaudewitz, D. et al. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb. Haemost. 110, 609\u2013615 (2013).","journal-title":"Thromb. Haemost."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62835-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:17:10Z","timestamp":1670318230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62835-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62835-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"2 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5845"}}